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Abstract
Identifying gene-gene interactions or gene-environment interactions in studies of human complex diseases remains a big
challenge in genetic epidemiology. An additional challenge, often forgotten, is to account for important lower-order genetic
effects. These may hamper the identification of genuine epistasis. If lower-order genetic effects contribute to the genetic
variance of a trait, identified statistical interactions may simply be due to a signal boost of these effects. In this study, we
restrict attention to quantitative traits and bi-allelic SNPs as genetic markers. Moreover, our interaction study focuses on 2-
way SNP-SNP interactions. Via simulations, we assess the performance of different corrective measures for lower-order
genetic effects in Model-Based Multifactor Dimensionality Reduction epistasis detection, using additive and co-dominant
coding schemes. Performance is evaluated in terms of power and familywise error rate. Our simulations indicate that
empirical power estimates are reduced with correction of lower-order effects, likewise familywise error rates. Easy-to-use
automatic SNP selection procedures, SNP selection based on ‘‘top’’ findings, or SNP selection based on p-value criterion for
interesting main effects result in reduced power but also almost zero false positive rates. Always accounting for main effects
in the SNP-SNP pair under investigation during Model-Based Multifactor Dimensionality Reduction analysis adequately
controls false positive epistasis findings. This is particularly true when adopting a co-dominant corrective coding scheme. In
conclusion, automatic search procedures to identify lower-order effects to correct for during epistasis screening should be
avoided. The same is true for procedures that adjust for lower-order effects prior to Model-Based Multifactor Dimensionality
Reduction and involve using residuals as the new trait. We advocate using ‘‘on-the-fly’’ lower-order effects adjusting when
screening for SNP-SNP interactions using Model-Based Multifactor Dimensionality Reduction analysis.
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Introduction
Complex diseases commonly occur in a population and are a
major source of discomfort, disability and death worldwide. They
are believed to arise from multiple predisposing factors, both
genetic and non-genetic, each factor potentially having a
modifying effect on the other. Detecting gene-gene interactions
or epistasis in studies of human complex diseases is a big challenge
in genetic epidemiology. An additional challenge is to account for
important lower-order genetic effects in order to reduce false
positive epistasis results. To date, several strategies are available,
within the context of genetic association studies that specifically
aim to identify and characterize gene-gene interactions. Among
these strategies is the Model-Based Multifactor Dimensionality
Reduction (MB-MDR) which was first introduced by Calle et al.
[1]. The strategy of MB-MDR to tackle the dimensionality
problem in interaction detection involves reducing a potentially
high dimensional problem to a one-dimensional problem by
pooling multi-locus genotypes into three groups based on
association testing or modeling. Those multi-locus genotypes
exhibiting some significant evidence of increasing or decreasing
phenotypic mean, are labeled High group and Low group,
respectively. In addition, those multi-locus genotypes that either
show no evidence of association or have no sufficient sample size
contribute to an additional third Model-Based Multifactor
Dimensionality Reduction category, that of ‘No Evidence for
association’. It has been suggested that Model-Based Multifactor
Dimensionality Reduction is a useful method for identifying gene-
gene interactions in case-control or family-based design for both
dichotomous and quantitative traits [1,2,3,4,5,6]. For more details
on MB-MDR, we refer to the aforementioned articles. Although a
power study of MB-MDR detection with and without main effects
adjustment has been performed before [4,6], these studies only
involve adjusting for the known functional SNPs contributing to an
epistasis effect. The preliminary results these studies gave rise to,
emphasized the importance of lower-order effects adjustment
when searching for gene-gene interactions and warranted a more
detailed investigation.
PLoS ONE | www.plosone.org 1 January 2012 | Volume 7 | Issue 1 | e29594In this study, we perform a thorough simulation-based
investigation of the power of quantitative trait MB-MDR to
identify gene-gene interactions, using different strategies to adjust
for lower-order genetic effects, that may or not be part of the
(functional) SNP-SNP interaction under investigation. Perfor-
mance criteria used are power and familywise error rate. We
perform MB-MDR epistasis analyses first without any adjustment
for main effects and then with adjustments using several strategies.
The proposed main effects corrections can be grouped into two
categories: 1) main effects screening followed by MB-MDR
applied to an adjusted trait and 2) main effect adjustment
integrated in step 1 and step 2 of MB-MDR. These are depicted
in Figure 1 and described in more detail in the methods section.
Methods
MB-MDR
We apply a quantitative trait MB-MDR as described in
Mahachie John et al. [6] and its generalization to main effects
corrections. For a sufficiently frequent bi-allelic marker, there are
3 theoretically possible genotypes. Hence, 2 bi-allelic markers give
rise to 9 multi-locus cells. Each of the 9 multi-locus genotype cells
alternatively constitute group 1. The remaining 8 multi-locus
genotypes constitute group 2. The key MB-MDR steps are
summarized in Figure 2. In MB-MDR step 1, we make use of a
Student t-test at significance level 0.1 to compare the mean trait
values in the 2 aforementioned groups of multi-locus genotypes. In
step 2, we use the cell-based results of step 1 to label significant
cells as H(igh) or L(ow) and non significant ones as ‘no evidence’,
O. The sign of the Student’s t-test statistic is used to distinguish
between H and L: a positive (negative) sign refers to H (L). The
result is a new categorical variable with labels H, L and O. A new
association test is then performed for the newly created construct
on the trait, Y. In particular, we consider the maximum of Student
t-tests comparing the H-cells versus {L,O}-cells and L-cells versus
{H,O}-cells. In step 3, we assess the overall significance by
adopting a permutation-based maxT correction [7] with 999
replicates. Although in this study we focus on 2-locus interactions,
the principle of MB-MDR can be extended to single SNP-analysis
(hereafter referred to as MB-MDR1D) and higher-order (.2)
interactions (under construction).
Several methods exist to correct for lower-order effects in the
context of quantitative MB-MDR epistasis screening. An
overview of the considered methods in this study is given in
Figure 2. A first strategy is to extensively look for potentially
confounding main effects to transform the original trait to an
adjusted trait and to submit this newly defined trait to MB-MDR
for epistasis screening.
When correcting for main effects, a note about how to best code
lower-order effects is warranted. In a GWA study, SNPs are often
coded in an additive way [8]. This coding works well in practice,
although power can be gained by acknowledging the true
underlying genetic models [9]. For instance, if the two homozygote
genotypes at a locus exhibit the same risk, different from the
Figure 1. Different approaches to adjust for lower-order effects in MB-MDR epistasis screening.
doi:10.1371/journal.pone.0029594.g001
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have reduced power irrespective of the sample size [10].
Alternatively, several coding schemes may be investigated and a
maximum statistic over screened main effects models may be
selected [11]. The differing unknown operating modes of
inheritance throughout the genome make it hard to flexibly and
automatically acknowledge this complex inheritance spectrum.
Therefore, the route chosen in this paper, now in an epistasis
context is to correct for main effects by either assuming an additive
or a co-dominant coding scheme, in scenarios that involve
different contributions of additive and dominance variance to
main effects variance. Although some of these scenarios may be
better captured by non-additive and non-co-dominant codings, the
interest is in finding an all-purpose acceptable (in terms of power
Figure 2. Summary of the steps involved in MB-MDR analysis.
doi:10.1371/journal.pone.0029594.g002
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influencing epistasis signals. Choosing between additive and co-
dominant coding schemes implies choosing between the least and
most severe such removal of effects.
Main effects screening prior to MB-MDR
This screening procedure involves first adjusting for a chosen
subset of main effects via parametric (linear) regression models and
then considering residuals from the fitted models as a new trait for
MB-MDR. For the adjustment methods involving significance
assessments, we remark that whenever none of the SNPs are
significant, the original trait is submitted to MB-MDR.
Single (univariate) regression-based searches. Important
main effects can be identified via single-SNP regression models,
as is done in a classical GWA setting. Hence, SNPs that meet a
stringent criterion (such as governed by a Bonferroni criterion)
will be labelled as ‘‘important’’ and are therefore good candidates
to correct for in an epistasis screening. In this study, we prefer to
take a less conservative route, such as a selection based on step-
down maxT adjusted p-values with 999 replicates (Figure 1;
SRperm). However, targeting effects standing out in a GWA main
effects screening while maintaining overall type I error is quite
different from targeting main effects to adjust for in an epistasis
screening. Therefore, we also consider selecting ‘‘optimal’’ SNPs
for main effects correction in the quantitative MB-MDR
screening on the basis of their significance without correction
for multiple testing (Figure 1; SR0.05) or on the basis of a ranking
of the corresponding raw p-values (Figure 1; SRtop5,S R top10,
SRtop15).
Multiple regression-based searches. Due to a large
number of SNPs that are involved in a main effects genome-
wide analysis, multiple regression-based searches are often
automated. One such automated approach uses stepwise
selection based on AIC (stepAIC in R package MASS, R
2.10.0). This procedure iteratively adds and/or drops variables
to seek the lowest AIC score. The final model generates the list of
main effects to correct for in the quantitative trait MB-MDR
analysis (Figure 1; MRAIC).
Main effects adjustment as an integral part of MB-
MDR. In this scenario, main effects are adjusted for ‘‘on-the-
fly’’, i.e. SNPs are adjusted for during the first 2 MB-MDR
epistasis screening steps. Three types of adjustment are
considered. A first type is to always adjust for the SNPs in the
pair under investigation (Figure 1; MB-MDRadjust). Hence, the
adjustment is done irrespective of whether a main effect is truly
present. A second type is to only adjust for SNPs that are
identified by MB-MDR1D as significant. Here, MB-MDR1D is
run first and a list of genome-wide significant SNPs is identified
(based on step-down maxT with 999 permutation replicates).
MB-MDR epistasis screening is then performed while only
adjusting for the identified SNPs for the pair under investigation
(Figure 1; MB-MDR1D). A third type is to only adjust for
significant SNPs obtained via single regression models and
maxT significance assessment (Figure 1; MB-MDRlist). Thus, for
MB-MDR1D and MB-MDRlist, any of the following 3 situations
c a na r i s e :a )N o n eo ft h e2S N P si ss i g n i f i c a n ta n dn oc o r r e c t i o n
is performed b) One of the 2 SNPs is significant and this is
adjusted for c) Both SNPS are significant and both SNPs are
adjusted for.
In order to account for potentially important SNPs as an
integral part of MB-MDR, we remark that the Student’s t-test in
MB-MDR steps 1–2 (Figure 2) is replaced by the Wald test for the
interaction effect in a regression framework.
Data Simulation
Simulated data as generated in Mahachie John et al. [6] are
based on two epistasis models for SNP1 and SNP2 that
incorporate varying degrees of epistasis: Model M27 and Model
M170 of [12]. In order to increase the phenotypic mean, M27
requires an individual to have at least one copy of the minor allele
at both loci whereas M170 requires an individual to be
heterozygous at one locus and homozygous at the other. The
phenotypic means for the aforementioned epistasis models only
take two values, mL (Low phenotypic mean) and mH (High
phenotypic mean). The total phenotypic variance s2
tot, i.e. the
sum of genetic variance at both loci 2s2
1~s2
main (the minor allele
frequencies for the functional SNPs are taken to be the same),
epistasis variance s2
epi, and environmental variance s2
env, is fixed at
1. As a consequence, the total genetic variance, s2
g , for the two-
locus model consisting of main effects variance and epistasis
variance has an interpretation of a broad heritability measure.
SNP1 and SNP2 have MAF equal to p, with p one of
f0:1,0:25,0:5g. The MAFs of the other 98 markers are generated
from a random uniform distribution, U(0.05,0.5). MB-MDR
screening is performed on 100 SNPs in Hardy-Weinberg
Equilibrium and linkage equilibrium. The total genetic variance
s2
g is varied as s2
g[f0:01,0:02,0:03,0:05,0:5g. The main effects
variance s2
main consists of additive variance s2
add and dominance
variance s2
dom.A sp increases, the contribution to the total genetic
variance of epistasis variance relative to main effects variance
increases for M170 and decreases for M27, and also the
contributions of additive and dominance variance to the total
main effects variance change with p (Table 1).
For SNP3 and SNP4 , main effects are imposed with associated
variances s2
3 and s2
4, selected from a uniform distribution U(0,
0.06) such that the total main effects variance of the 4 loci (SNP1,
SNP2, SNP3, SNP4) is s2
main~2s2
1zs2
3zs2
4. The respective
modes of inheritance for SNP3 and SNP4 are additive and
advantageous heterozygous. Note that SNP4 will therefore
contribute to both the additive and dominance components of
the main effects variance. This scenario allows us to investigate the
effect of global main effects correction approaches for functional
SNPs that are not part of a two-locus interaction.
In addition data are simulated under the null model for the
functional pair (i.e. s2
g~0) in two ways, giving rise to two null
hypotheses H01 and H02. H01 : no genetic contribution apart from
SNP3 and SNP4 as main effects and H02 : no genetic contribution
from any of the SNPs whatsoever.
In summary, a total of 36 simulation settings are considered. For
each parameter setting, we consider 500 simulation replicates,
involving 2000 unrelated individuals.
Table 1. Theoretically derived proportions of the genetic
variance due to main effects (additive and dominance) or
epistasis.
Model p s
2
main/s
2
gen s
2
add/s
2
main s
2
dom/s
2
main s
2
epi/s
2
gen
0.1 0.319 0.947 0.053 0.681
M27 0.25 0.609 0.857 0.143 0.391
0.5 0.857 0.667 0.333 0.143
0.1 0.581 0.780 0.220 0.419
M170 0.25 0.118 0.400 0.600 0.882
0.5 0.000 0.947 0.053 1.000
doi:10.1371/journal.pone.0029594.t001
MB-MDR with Lower-Order Effects Correction
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Familywise error rates and false positive rates
Table 2 shows results for settings simulated under the null
hypotheses H01 and H02 of no genetic associations with the trait,
yet in the presence or absence of additional main effects (SNP3
and SNP4).
We observe that MB-MDR type I error percentages are close
to the nominal type I error rate of 5%, when no correction for
main effects is performed under settings where no additional
main effects act on the quantitative trait. Type I error rates are
also kept under control when correction for main effects is
integrated in MB-MDR epistasis screening as well as prior to
MB-MDR for permutation based regression-based approach
(MB-MDRadjust,M D - M D R 1D, MB-MDRlist and SRperm, respec-
tively). In particular, additive correction under H02 and co-
dominant correction for both H01 and H02. When additional
main effects are present in the data, adjusting for their effects
using additive correction give rise to inflated type I error rates
ranging from 55 to 74%. In contrast, when adopting a co-
dominant correction, type I error is under control for MRAIC,
and single regression-based correction methods (except SRperm)
which are extremely conservative (Table 2: type I error rates are
close to zero).
False positive rate estimates generated by MB-MDR (i.e.
referring to scenarios for which one or more significantly
Table 2. Type I error percentages for data generated under the null hypothesis of no genetic association of the interacting pair.
Without correction and additional main effects
P Present absent
0.1 0.982 0.046
0.25 No correction 0.984 0.050
0.5 0.982 0.050
With Correction and additional main effects
Way of Correction Additive Co-dominant
present absent present Absent
0.1 0.676 0.048 0.040 0.052
0.25 MB-MDRadjust 0.710 0.034 0.054 0.038
0.5 0.740 0.044 0.036 0.050
0.1 0.676 0.036 0.058 0.030
0.25 MB-MDR1D 0.722 0.040 0.042 0.036
0.5 0.746 0.040 0.038 0.030
0.1 0.682 0.038 0.056 0.030
0.25 MB-MDRlist 0.726 0.036 0.044 0.032
0.5 0.748 0.046 0.040 0.032
0.1 0.628 0.038 0.048 0.030
0.25 SRperm 0.660 0.036 0.058 0.030
0.5 0.678 0.046 0.044 0.032
0.1 0.576 0.014 0.006 0.010
0.25 SR0.05 0.604 0.006 0.012 0.000
0.5 0.636 0.022 0.008 0.008
0.1 0.552 0.008 0.000 0.002
0.25 MRAIC 0.578 0.004 0.002 0.000
0.5 0.616 0.012 0.000 0.006
0.1 0.582 0.014 0.008 0.008
0.25 SRtop5 0.616 0.002 0.020 0.000
0.5 0.638 0.026 0.010 0.010
0.1 0.560 0.012 0.000 0.008
0.25 SRtop10 0.592 0.006 0.004 0.000
0.5 0.626 0.022 0.006 0.006
0.1 0.556 0.010 0.000 0.006
0.25 SRtop15 0.588 0.006 0.002 0.000
0.5 0.618 0.016 0.004 0.006
Results are for scenarios: with and without additional main effects (SNP3 and SNP4) contributing to the genetic variance. In bold are values within Bradley’s liberal
criterion of robustness.
doi:10.1371/journal.pone.0029594.t002
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using no correction or an additive or co-dominant correction of
main effects, are shown in Figure 3. When no correction is
performed, false positive rate estimates are around 100% under
both M170 and M27 genetic epistasis models. In general, for
additive correction false positive rate estimates range from 53 to
100% whereas for co-dominant correction, false positive rate
estimates are lower and range from 0 to 19%. In particular, false
positive rates for MB-MDRadjust (always adjusting for main effects
SNPs) in a co-dominant way range from 4 to 7%, rates that are
within the interval (0.025, 0.075), satisfying Bradley’s [13] liberal
criterion of robustness. This criterion requires that the type I
error rates are controlled for any level a of significance, if the
empirical type I error rate ^ a a is contained in the interval
0:5aƒ^ a aƒ1:5a. For MB-MDR1D and MB-MDRlist, false positive
rates are not kept under control. The actual numerical results of
the false positive profiles plotted in Figure 3 are presented in the
Table S1 for M170 and Table S2 for M27. The main reason why
we observe higher false positive rates under additive correction is
due to the fact that SNP4 contributes to both an additive and
dominance component of the main effects variance. Hence, there
is also a higher chance of identifying ‘significant’ interactions for
pairs involving SNP4. False positive rates are reduced when co-
dominant correction is performed. Table 3 shows observed false
positive rates that involve pairing with SNP3 and/or SNP4 under
additive and co-dominant correction. Only MB-MDRadjust (‘‘on-
the-fly’’ adjustment) results are shown. From Table 3, g
2.0, we
observe that under additive codings, false positive rates range
from 51 to 61% for interactions between SNP3 and SNP4.
However, for interactions with SNP3 (excluding SNP3, SNP4
interaction), false positive rates range from 0 to 6%, except for
Model 27, p=0.5 and g
2 of 0.05 and 0.1 where false positive rates
are 27 and 92%, respectively. As observed in Table 1, model
M27, p=0.5 has the highest relative contribution of dominance
variance, hence, additive correction does not fully account for
SNP1 and SNP2.
Empirical power estimates
Power profiles of MB-MDR to detect the correct interacting
pair (SNP1, SNP2) without and with different ways of adjustment
of main effects are shown in Figure 4. Empirical power estimates
are presented as Table S1 for M170 and Table S2 for M27. In this
section, we focus on scenarios where there is some remarkable
degree of main effects contributing to the genetic variance (M170:
p=0.1, M27: p=0.25 and 0.5). For a detailed view on variance
decomposition into main and epistatic effects, we refer to [6].
Under the aforementioned scenarios, the profile for no correction
always has the highest power. Under M170, the empirical power
estimates for this profile range from 33 to 100% for p=0.1. Under
M27, the power estimates range from 27 to 100% and from 15 to
100%, for p=0.25 and 0.5 respectively. Irrespective of whether
main effects are corrected for using additive or co-dominant
coding, profiles for the considered multiple-regression, MRAIC and
single regression-based methods that do not involve multiple
testing (SR0.05,S R top5,S R top10 and SRtop15) tend to follow the
same trajectory, giving rise to the lowest empirical power
estimates. With additive adjustments, empirical power estimates
for these corrective ways range from 0 to 100% for both models
M27 and M170. With co-dominant adjustments, power estimates
range from 0 to 93% , for M170, p=0.1, from 0 to 100% and
from 0 to 18%, for model M27, p=0.25 and p=0.5 respectively.
Estimates for MB-MDRadjust (corrective methods that are
integrated as part of MB-MDR) , range from 6 to 100% for
M170, p=0.1, from 3 to 100% for M27 with p=0.25 and from 1
to 100% for M27 with p=0.5, when additive corrections are
performed. Under co-dominant corrections the estimates range
from 4 to 100% for M170 (p=0.1) and from 4 to 100% or from 0
to 68% for M27 (p=0.25 and p=0.5 respectively).
Discussion
The identification of genetic susceptibility loci for human
complex diseases has been rather successful due to the ability to
Figure 3. False positive percentages of MB-MDR based on additive (A) and co-dominant (B) correction. False positive percentage is
defined as the proportion of simulation samples for which pairs other than the causal pair (SNP1, SNP2) are significant.
doi:10.1371/journal.pone.0029594.g003
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analyses. In the quest for the missing heritability, genome-wide
association interaction studies have become increasingly popular
and the field shows a boost in methodological developments [14].
When lower-order effects are not appropriately accounted for in
epistasis screening, derived results may not be trustworthy and
conclusions about genuine epistasis may be ungrounded.
Indeed, the challenge is to find epistasis effects above and
beyond singular marker contributing effects, should there be any.
In this work, we investigated the power of MB-MDR for
quantitative traits and unrelated individuals, while targeting
gene–gene interactions accounting for potential main effects.
As was already observed in [6], MB-MDR adequately controls
type I rate at 5% when no association is present (null data). Under
additive corrections, type I error and false positive rates are high
irrespective of the adjustment method considered but controlled
under co-dominant corrections. This is due to the existence of
SNP4, which was simulated with both additive and dominance
effects (advantageous heterozygous). Hence, additive adjustment
does not fully remove the effect of SNP4. As shown before in
Table 3, the consequence is that a number of SNPs appear to be
significantly interacting with SNP4. Not surprisingly, this occurs
more often under additive correction compared to co-dominant
correction. This is because when we correct for main effects using
the co-dominant model, we remove all the effect of SNP4, and
hence false positive results are only by chance (5% nominal error
rate). When no main effects adjustment is implemented, MB-
MDR gives even higher false positive rate rates.
Table 3. False positive percentages of MB-MDRadjust involving SNP3 and/or SNP4.
Additive Co-dominant
Pg
2
SNP3_
anyotherthanSNP4 SNP3_SNP4
SNP4_
anyotherthanSNP3
SNP3_
anyotherthanSNP4 SNP3_SNP4
SNP4_
anyotherthanSNP3
0.1 0.002 0.520 0.660 0.000 0.000 0.000
H01 0.25 0 0.000 0.556 0.688 0.000 0.000 0.000
0.5 0.002 0.608 0.722 0.004 0.000 0.002
0.01 0.002 0.584 0.704 0.004 0.000 0.000
0.02 0.008 0.582 0.724 0.002 0.000 0.000
0.1 0.03 0.000 0.572 0.690 0.000 0.000 0.000
0.05 0.008 0.534 0.676 0.002 0.000 0.000
0.1 0.072 0.540 0.752 0.000 0.000 0.000
0.01 0.002 0.598 0.714 0.000 0.000 0.004
0.02 0.000 0.558 0.712 0.002 0.000 0.002
M170 0.25 0.03 0.000 0.544 0.686 0.000 0.000 0.000
0.05 0.004 0.536 0.706 0.002 0.000 0.000
0.1 0.032 0.566 0.738 0.000 0.000 0.000
0.01 0.000 0.526 0.664 0.000 0.000 0.002
0.02 0.000 0.588 0.708 0.000 0.000 0.002
0.5 0.03 0.002 0.544 0.692 0.002 0.000 0.002
0.05 0.002 0.550 0.666 0.000 0.000 0.000
0.1 0.002 0.528 0.662 0.002 0.000 0.000
0.01 0.002 0.532 0.662 0.000 0.000 0.000
0.02 0.000 0.564 0.690 0.000 0.000 0.000
0.1 0.03 0.000 0.554 0.680 0.002 0.000 0.000
0.05 0.000 0.562 0.704 0.002 0.000 0.000
0.1 0.000 0.518 0.638 0.000 0.000 0.000
0.01 0.002 0.512 0.652 0.000 0.000 0.002
0.02 0.004 0.520 0.682 0.004 0.000 0.000
M27 0.25 0.03 0.000 0.562 0.700 0.002 0.000 0.000
0.05 0.000 0.546 0.700 0.000 0.000 0.002
0.1 0.042 0.564 0.734 0.002 0.000 0.000
0.01 0.000 0.546 0.672 0.000 0.000 0.002
0.02 0.020 0.508 0.684 0.000 0.000 0.000
0.5 0.03 0.060 0.518 0.706 0.000 0.000 0.002
0.05 0.272 0.536 0.806 0.000 0.000 0.000
0.1 0.912 0.590 0.974 0.000 0.000 0.000
False positive percentages shown are for identifying interaction between SNP3 and SNP4 and for interactions between SNP3 or SNP4 and at least one other SNP for null
data scenario under H01 and for models M170 and M27.
doi:10.1371/journal.pone.0029594.t003
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are explained by the different contributions of additive and
dominance effects to the total main effects variance as already
shown in Table 1. When there is a remarkable contribution of
dominance effect, as mentioned before, additive coding does not
fully remove main effect contribution of the interacting SNPs. For
instance, under M27, when the contribution of main effects is
maximum (p=0.5), almost 33% of the main effects variance is
dominance, hence a huge difference in the power profiles between
additive and co-dominant codings.
Interestingly, easy-to-use automatic subset selection procedures
(MRAIC) and single regression-based identification of important
main effects prior to MB-MDR screening result in lower power
and almost zero false positive rates. Often, a list of top SNPs is
generated to derive disease genetic risk scores. Some of these SNPs
may reach user-defined significance, some may even reach
genome-wide significance and some may not be significant at all.
Hence, correcting for SNPs in such a list (e.g. top5, 10, 15) may
remove more of the trait’s variability than is really necessary,
especially when correction for multiple testing is not performed.
Note that we considered a minimum of 5 top findings since at least
4 SNPs were allowed to contribute to the main effects variance.
In order to attain sufficient power, any main effects corrective
method that leads to an over-correction during epistasis screening
should be avoided. All considered residual-based approaches
(MRAIC, SR0.05, SRperm, SRtop5, SRtop10, SRtop15) led to
uncontrolled false positive rates. This can be explained by either
the way the residuals were obtained (inappropriate main effects
coding) or by the non-exhaustive list of markers considered in the
residual computation.
Only co-dominantly correcting for significant SNPs as integral
part of MB-MDR screening perform much better. However, the
poor performance of MB-MDR1D and MB-MDRlist and the
excellent performance of MB-MDRadjust in terms of controlling
false positive epistasis rates supports the intuition that it (only)
matters to correct for those SNPs that are involved in the SNP pair
under investigation, when no other SNPs are expected to modify
the effect of that pair.
The aforementioned discussion clearly raises questions about
how to best correct for lower-order effects when higher-order (.2)
interactions are targeted. In either case, to aid in interpretation of
results, it is always a good practice to assess the joint information of
clusters of SNPs that contribute to the trait variability [15].
Finally, we emphasize that most statistical epistasis detection
methods can be decomposed into a core component and a
multiple testing correction component. Keeping the core
component, but using a more refined multiple testing correction
can generally enhance its performance. For instance, assumptions
underlying the maxT procedure of [7] that is implemented in
MB-MDR are likely to be violated for MB-MDR1D and MB-
MDRlist . Indeed, the null and the alternative hypotheses per pair
of SNPs under investigation are no longer the same for all
interaction tests.
In conclusion, rather than adjusting for lower-order effects prior
to MB-MDR and using residuals as the new trait, or adjusting only
for significant SNP(s), we advocate an ‘‘on-the-fly’’ main effects
adjustment (MB-MDRadjust). This type of adjustment only
removes potential main effects contributions in the pair under
investigation but keeps the null and alternative hypotheses similar
from one pair of SNPs to another. We have shown that the
commonly used additive coding in the ‘‘on-the-fly’’ adjustment
(MB-MDRadjust) is not sufficient and leads to overly optimistic
results and that co-dominant adjustments are to be preferred. This
will ensure an acceptable balance between type I error and power
to identify the interactions.
Realistic settings often involve both additive and dominance
genetic effects to the trait under investigation. Equivalent to our co-
dominant coding, a perhaps biologically more meaningful coding
involves introducing 2 variables X1 and X2 with values 21, 0, 1
and 21/2, 1/2, 21/2, respectively, for homogenous wild type,
heterozygote and homozygote mutant genotypes. In such a coding
scheme, both additive and dominant scales are represented. This 2-
parameter coding is statistically attractive since it is invariant to
allele coding (i.e. whether coding homogenous wild type as 1 or
homozygote mutant genotypes as 1 for X1) [16]. The utility of the
aforementioned coding as a way to adjust for lower-order effects in
Figure 4. Power to identify SNP1, SNP2, as significant for additive (A) and co-dominant (B) correction.
doi:10.1371/journal.pone.0029594.g004
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future research.
Software
The MB-MDR software with the MB-MDRadjust option is
available upon request from the first author (jmahachie@ulg.ac.
be).
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